HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.

Abstract
We have previously shown that p38 mitogen-activated protein kinase (MAPK) inhibitors, which block the production and action of inflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-1 (IL-1), are effective in models of bone and cartilage degradation. To further investigate the role of p38 MAPK, we have studied its activation in osteoblasts and chondrocytes, following treatment with a panel of proinflammatory and osteotropic agents. In osteoblasts, significant activation of p38 MAPK was observed following treatment with IL-1 and TNF, but not parathyroid hormone, transforming growth factor-beta (TGF-beta), 1,25(OH)(2)D(3), insulin-like growth factor-1 (IGF-1), or IGF-II. Similar results were obtained using primary bovine chondrocytes and an SV40-immortalized human chondrocyte cell line, T/C28A4. SB 203580, a selective inhibitor of p38 MAPK, inhibited IL-1 and TNF-induced p38 MAPK activity and IL-6 production (IC(50)s 0.3--0.5 microM) in osteoblasts and chondrocytes. In addition, IL-1 and TNF also activated p38 MAPK in fetal rat long bones and p38 MAPK inhibitors inhibited IL-1- and TNF-stimulated bone resorption in vitro in a dose-dependent manner (IC(50)s 0.3--1 microM). These data support the contention that p38 MAPK plays a central role in regulating the production of, and responsiveness to, proinflammatory cytokines in bone and cartilage. Furthermore, the strong correlation between inhibition of kinase activity and IL-1 and TNF-stimulated biological responses indicates that selective inhibition of the p38 MAPK pathway may have therapeutic utility in joint diseases such as rheumatoid arthritis (RA).
AuthorsS Kumar, B J Votta, D J Rieman, A M Badger, M Gowen, J C Lee
JournalJournal of cellular physiology (J Cell Physiol) Vol. 187 Issue 3 Pg. 294-303 (Jun 2001) ISSN: 0021-9541 [Print] United States
PMID11319753 (Publication Type: Journal Article)
CopyrightCopyright 2001 Wiley-Liss, Inc.
Chemical References
  • Calcium Radioisotopes
  • Cytokines
  • Enzyme Inhibitors
  • Growth Substances
  • Interleukin-1
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Biological Assay
  • Bone Resorption (enzymology)
  • Calcium Radioisotopes (analysis, metabolism)
  • Cattle
  • Cells, Cultured
  • Chondrocytes (cytology, drug effects, enzymology)
  • Culture Techniques
  • Cytokines (pharmacology)
  • Dose-Response Relationship, Drug
  • Enzyme Activation (drug effects, physiology)
  • Enzyme Inhibitors (pharmacology)
  • Growth Substances (pharmacology)
  • Humans
  • Interleukin-1 (metabolism, pharmacology)
  • Interleukin-6 (biosynthesis)
  • Mitogen-Activated Protein Kinases (antagonists & inhibitors, metabolism)
  • Osteoblasts (cytology, drug effects, enzymology)
  • Radius (cytology, embryology, enzymology)
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction (drug effects, physiology)
  • Tumor Necrosis Factor-alpha (metabolism, pharmacology)
  • Ulna (cytology, embryology, enzymology)
  • p38 Mitogen-Activated Protein Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: